Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 493

1.

Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p.

Idichi T, Seki N, Kurahara H, Fukuhisa H, Toda H, Shimonosono M, Yamada Y, Arai T, Kita Y, Kijima Y, Mataki Y, Maemura K, Natsugoe S.

Oncotarget. 2018 Jun 22;9(48):28849-28865. doi: 10.18632/oncotarget.25599. eCollection 2018 Jun 22.

2.

Expression of SOX9 Is Related to Prognosis in Patients with Oesophageal Squamous Cell Carcinoma.

Higo N, Okumura H, Uchikado Y, Omoto I, Sasaki K, Kita Y, Ryosuke D, Noda M, Owaki T, Ishigami S, Natsugoe S.

In Vivo. 2018 Jul-Aug;32(4):835-838. doi: 10.21873/invivo.11316.

PMID:
29936467
3.

Effect of visual feedback during laparoscopic basic training using a box trainer with a transparent top.

Maemura K, Mataki Y, Kurahara H, Kawasaki Y, Mori S, Iino S, Sakoda M, Ueno S, Shinchi H, Natsugoe S.

Ann Gastroenterol Surg. 2017 Jun 7;1(2):129-135. doi: 10.1002/ags3.12010. eCollection 2017 Jun.

4.

Novel surgical approach based on the sentinel node concept in patients with early gastric cancer.

Natsugoe S, Arigami T, Uenosono Y, Yanagita S.

Ann Gastroenterol Surg. 2017 Aug 31;1(3):180-185. doi: 10.1002/ags3.12027. eCollection 2017 Sep. Review.

5.

Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.

Ando K, Sakoda M, Ueno S, Hiwatashi K, Iino S, Minami K, Kawasaki Y, Hashiguchi M, Tanoue K, Mataki Y, Kurahara H, Maemura K, Shinchi H, Natsugoe S.

Anticancer Res. 2018 Jun;38(6):3411-3418. doi: 10.21873/anticanres.12609.

PMID:
29848691
6.

The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis.

Shimonosono M, Arigami T, Yanagita S, Matsushita D, Uchikado Y, Kijima Y, Kurahara H, Kita Y, Mori S, Sasaki K, Omoto I, Maemura K, Uenosono Y, Ishigami S, Natsugoe S.

Oncotarget. 2018 Apr 24;9(31):22069-22078. doi: 10.18632/oncotarget.25179. eCollection 2018 Apr 24.

7.

A Therapeutic Strategy for Resectable Pancreatic Cancer Based on Risk Factors of Early Recurrence.

Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kawasaki Y, Arigami T, Mori S, Kijima Y, Ueno S, Shinchi H, Natsugoe S.

Pancreas. 2018 Jul;47(6):753-758. doi: 10.1097/MPA.0000000000001066.

PMID:
29771771
8.

Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma.

Minami K, Hiwatashi K, Ueno S, Sakoda M, Iino S, Okumura H, Hashiguchi M, Kawasaki Y, Kurahara H, Mataki Y, Maemura K, Shinchi H, Natsugoe S.

Exp Ther Med. 2018 May;15(5):4465-4476. doi: 10.3892/etm.2018.5959. Epub 2018 Mar 14.

9.

Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial.

Shimizu N, Oki E, Tanizawa Y, Suzuki Y, Aikou S, Kunisaki C, Tsuchiya T, Fukushima R, Doki Y, Natsugoe S, Nishida Y, Morita M, Hirabayashi N, Hatao F, Takahashi I, Choda Y, Iwasaki Y, Seto Y.

Surg Today. 2018 May 2. doi: 10.1007/s00595-018-1665-4. [Epub ahead of print]

PMID:
29721714
10.

Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.

Idichi T, Seki N, Kurahara H, Fukuhisa H, Toda H, Shimonosono M, Okato A, Arai T, Kita Y, Mataki Y, Kijima Y, Maemura K, Natsugoe S.

Cancer Sci. 2018 Jun;109(6):2013-2026. doi: 10.1111/cas.13610. Epub 2018 May 22.

11.

[A Case of Adult Undifferentiated Sarcoma of the Liver with Intraatrial Metastasis].

Minami K, Sakoda M, Iino S, Hiwatashi K, Maemura K, Mataki Y, Kurahara H, Kawasaki Y, Tsuruda Y, Setoyama T, Okumura H, Maenohara S, Natsugoe S.

Gan To Kagaku Ryoho. 2018 Apr;45(4):721-724. Japanese.

PMID:
29650847
12.

[Curative Resection for Unresectable Locally Advanced Colorectal Cancer Following Intensive Chemotherapy plus Molecular Targeted Agent - Report of Three Cases].

Hozaka Y, Mori S, Kita Y, Baba K, Arigami T, Uenosono Y, Uchikado Y, Mataki Y, Maemura K, Natsugoe S.

Gan To Kagaku Ryoho. 2018 Apr;45(4):670-672. Japanese.

PMID:
29650830
13.

Corrigendum to "Clinical impact of circulating tumor cells and therapy response in pancreatic cancer" [43 (6) (2017) 1050-1055].

Okubo K, Uenosono Y, Arigami T, Mataki Y, Matsushita D, Yanagita S, Kurahara H, Sakoda M, Kijima Y, Maemura K, Natsugoe S.

Eur J Surg Oncol. 2018 Jun;44(6):860. doi: 10.1016/j.ejso.2018.03.015. Epub 2018 Mar 28. No abstract available.

PMID:
29605162
14.

Multidisciplinary therapy for metastatic primary malignant melanoma of the esophagus: A case report.

Sasaki K, Uchikado Y, Omoto I, Amatatsu M, Megumi K, Okumura H, Maemura K, Natsugoe S.

Mol Clin Oncol. 2018 Apr;8(4):533-538. doi: 10.3892/mco.2018.1572. Epub 2018 Feb 13.

15.

Quantitative assessment of fluorescence intensity of ICG in sentinel nodes in early gastric cancer.

Okubo K, Uenosono Y, Arigami T, Matsushita D, Yanagita S, Kijima T, Amatatsu M, Ishigami S, Maemura K, Natsugoe S.

Gastric Cancer. 2018 Mar 7. doi: 10.1007/s10120-018-0816-z. [Epub ahead of print]

PMID:
29516211
16.

Clinical significance of primary tumor score determined by tumor depth and size in patients with resectable gastric cancer.

Haraguchi N, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, Mori S, Kurahara H, Kijima Y, Nakajo A, Maemura K, Ishigami S, Natsugoe S.

Oncotarget. 2018 Jan 4;9(9):8512-8520. doi: 10.18632/oncotarget.23953. eCollection 2018 Feb 2.

17.

Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.

Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K.

Mol Clin Oncol. 2018 Jan;8(1):93-98. doi: 10.3892/mco.2017.1502. Epub 2017 Nov 15.

18.

Significance of Glucose Transporter Type 1 (GLUT-1) Expression in the Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma.

Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kawasaki Y, Arigami T, Mori S, Kijima Y, Ueno S, Shinchi H, Natsugoe S.

Ann Surg Oncol. 2018 May;25(5):1432-1439. doi: 10.1245/s10434-018-6357-1. Epub 2018 Feb 5.

PMID:
29404819
19.

Expression of gremlin1 in gastric cancer and its clinical significance.

Yamasaki Y, Ishigami S, Arigami T, Kita Y, Uchikado Y, Kurahara H, Kijima Y, Maemura K, Natsugoe S.

Med Oncol. 2018 Feb 2;35(3):30. doi: 10.1007/s12032-017-1073-4.

20.

[Case Report of an Acute Focal Bacterial Nephritis Associated with Adjuvant Chemotherapy in Esophageal Cancer Patient].

Tsuruda Y, Okumura H, Setoyama T, Hiwatashi K, Minami K, Maenohara S, Uchikado Y, Omoto I, Sasaki K, Natsugoe S.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1476-1478. Japanese.

PMID:
29394673
21.

Effect of Neoadjuvant Chemoradiotherapy on Lymph Node Micrometastases in Thoracic Esophageal Cancer.

Yanagi M, Sasaki K, Uchikado Y, Omoto I, Arigami T, Kurahara H, Uenosono Y, Sakoda M, Maemura K, Natsugoe S.

Anticancer Res. 2018 Feb;38(2):893-900.

PMID:
29374717
22.

Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer.

Amatatsu M, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, Kijima Y, Kurahara H, Kita Y, Mori S, Sasaki K, Omoto I, Maemura K, Ishigami S, Natsugoe S.

Cancer Sci. 2018 Mar;109(3):814-820. doi: 10.1111/cas.13508. Epub 2018 Feb 19.

23.

Usefulness of fluorescence vascular imaging for evaluating splenic perfusion.

Kawasaki Y, Maemura K, Kurahara H, Mataki Y, Iino S, Sakoda M, Shinchi H, Natsugoe S.

ANZ J Surg. 2018 Jan 8. doi: 10.1111/ans.14364. [Epub ahead of print]

PMID:
29316173
24.

Improved perioperative outcomes of laparoscopic distal pancreatosplenectomy: modified lasso technique.

Kawasaki Y, Hwang HK, Kang CM, Natsugoe S, Lee WJ.

ANZ J Surg. 2017 Dec 20. doi: 10.1111/ans.14351. [Epub ahead of print]

PMID:
29266719
25.

Management of horizontal duodenal perforation: a report of three cases and review of literature.

Nepal P, Maemura K, Mataki Y, Kurahara H, Kawasaki Y, Hiwatashi K, Iino S, Sakoda M, Arigami T, Ishigami S, Shinchi H, Natsugoe S.

Surg Case Rep. 2017 Dec 1;3(1):119. doi: 10.1186/s40792-017-0397-9.

26.

Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.

Noda M, Okumura H, Uchikado Y, Omoto I, Sasaki K, Kita Y, Mori S, Owaki T, Arigami T, Uenosono Y, Nakajo A, Kijima Y, Ishigami S, Maemura K, Natsugoe S.

Ann Surg Oncol. 2018 Feb;25(2):449-455. doi: 10.1245/s10434-017-6271-y. Epub 2017 Nov 29.

PMID:
29188501
27.

Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma.

Natsuizaka M, Whelan KA, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS, Que J, Yang Y, Katz JP, Wileyto EP, Basu D, Kita Y, Natsugoe S, Naganuma S, Klein-Szanto AJ, Diehl JA, Bass AJ, Wong KK, Rustgi AK, Nakagawa H.

Nat Commun. 2017 Nov 24;8(1):1758. doi: 10.1038/s41467-017-01500-9.

28.

Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).

Miyamoto Y, Tsuji A, Tanioka H, Maekawa S, Kawanaka H, Kitazono M, Oki E, Emi Y, Murakami H, Ogata Y, Saeki H, Shimokawa M, Natsugoe S, Akagi Y, Baba H, Maehara Y.

Int J Clin Oncol. 2018 Apr;23(2):402. doi: 10.1007/s10147-017-1212-0.

PMID:
29138948
29.

Clinical application and outcomes of sentinel node navigation surgery in patients with early gastric cancer.

Arigami T, Uenosono Y, Yanagita S, Okubo K, Kijima T, Matsushita D, Amatatsu M, Hagihara T, Haraguchi N, Mataki Y, Ehi K, Ishigami S, Natsugoe S.

Oncotarget. 2017 May 3;8(43):75607-75616. doi: 10.18632/oncotarget.17584. eCollection 2017 Sep 26.

30.

[A Case of Fournier's Gangrene Due to Perforation of Lower Rectal Cancer during Chemotherapy].

Fukuhisa H, Baba K, Kita Y, Tanabe H, Ijichi T, Mori S, Natsugoe S.

Gan To Kagaku Ryoho. 2017 Oct;44(10):935-937. Japanese.

PMID:
29066701
31.

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.

Yonemori K, Seki N, Idichi T, Kurahara H, Osako Y, Koshizuka K, Arai T, Okato A, Kita Y, Arigami T, Mataki Y, Kijima Y, Maemura K, Natsugoe S.

Oncotarget. 2017 Jul 26;8(41):70097-70115. doi: 10.18632/oncotarget.19591. eCollection 2017 Sep 19.

32.

Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy.

Baba M, Aikou T, Natsugoe S, Kusano C, Shimada M, Nakano S, Fukumoto T, Yoshinaka H.

Dis Esophagus. 2017 Nov 1;11(1):28-34. doi: 10.1093/dote/11.1.28.

PMID:
29040479
33.

Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial.

Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M.

Surg Today. 2017 Dec;47(12):1539-1540. doi: 10.1007/s00595-017-1589-4.

PMID:
28956067
34.

Clinical characteristics of breast cancer patients with mental disorders.

Shinden Y, Kijima Y, Hirata M, Nakajo A, Tanoue K, Arigami T, Kurahara H, Maemura K, Natsugoe S.

Breast. 2017 Dec;36:39-43. doi: 10.1016/j.breast.2017.08.010. Epub 2017 Sep 21.

PMID:
28942099
35.

Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.

Idichi T, Seki N, Kurahara H, Yonemori K, Osako Y, Arai T, Okato A, Kita Y, Arigami T, Mataki Y, Kijima Y, Maemura K, Natsugoe S.

Oncotarget. 2017 May 29;8(32):53180-53193. doi: 10.18632/oncotarget.18261. eCollection 2017 Aug 8.

36.

Indication of extrahepatic bile duct resection for gallbladder cancer.

Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kawasaki Y, Mori S, Arigami T, Kijima Y, Shinchi H, Natsugoe S.

Langenbecks Arch Surg. 2018 Feb;403(1):45-51. doi: 10.1007/s00423-017-1620-7. Epub 2017 Sep 5.

PMID:
28875312
37.

Surgical treatment for the excluded bile leakage from Spiegel lobe after right hemihepatectomy: A case report.

Fukuhisa H, Sakoda M, Hiwatashi K, Iino S, Minami K, Hashiguchi M, Kawasaki Y, Kurahara H, Mataki Y, Maemura K, Shinchi H, Ueno S, Natsugoe S.

Int J Surg Case Rep. 2017;39:159-163. doi: 10.1016/j.ijscr.2017.08.018. Epub 2017 Aug 18.

38.

Laparoscopic complete mesocolic excision via mesofascial separation for left-sided colon cancer.

Mori S, Kita Y, Baba K, Yanagi M, Tanabe K, Uchikado Y, Kurahara H, Arigami T, Uenosono Y, Mataki Y, Nakajo A, Maemura K, Natsugoe S.

Surg Today. 2018 Mar;48(3):274-281. doi: 10.1007/s00595-017-1580-0. Epub 2017 Aug 23.

PMID:
28836166
39.

Impact of Snail and E-cadherin expression in pancreatic neuroendocrine tumors.

Yonemori K, Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Ueno S, Shinchi H, Natsugoe S.

Oncol Lett. 2017 Aug;14(2):1697-1702. doi: 10.3892/ol.2017.6306. Epub 2017 Jun 2.

40.

Comparison of proton beam radiotherapy and hyper-fractionated accelerated chemoradiotherapy for locally advanced pancreatic cancer.

Maemura K, Mataki Y, Kurahara H, Kawasaki Y, Iino S, Sakoda M, Ueno S, Arimura T, Higashi R, Yoshiura T, Shinchi H, Natsugoe S.

Pancreatology. 2017 Sep - Oct;17(5):833-838. doi: 10.1016/j.pan.2017.07.191. Epub 2017 Jul 27.

PMID:
28778480
41.

Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.

Osako Y, Seki N, Koshizuka K, Okato A, Idichi T, Arai T, Omoto I, Sasaki K, Uchikado Y, Kita Y, Kurahara H, Maemura K, Natsugoe S.

J Hum Genet. 2017 Nov;62(11):935-944. doi: 10.1038/jhg.2017.69. Epub 2017 Jun 29.

PMID:
28659612
42.

Utility of the sentinel node concept for detection of lateral pelvic lymph node metastasis in lower rectal cancer.

Yanagita S, Uenosono Y, Arigami T, Kita Y, Mori S, Natsugoe S.

BMC Cancer. 2017 Jun 19;17(1):433. doi: 10.1186/s12885-017-3408-0.

43.

Multiple malignant epithelioid mesotheliomas of the liver and greater omentum: a case report and review of the literature.

Minami K, Okumura H, Hiwatashi K, Matsukita S, Setoyama T, Minamimagari K, Tsuruta Y, Kanetsuki I, Ogura Y, Maenohara S, Natsugoe S.

Surg Case Rep. 2017 Dec;3(1):66. doi: 10.1186/s40792-017-0342-y. Epub 2017 May 10.

44.

Clinical significance of circulating tumor cells in blood from patients with gastric cancer.

Arigami T, Uenosono Y, Yanagita S, Okubo K, Kijima T, Matsushita D, Amatatsu M, Kurahara H, Maemura K, Natsugoe S.

Ann Gastroenterol Surg. 2017 Apr 25;1(1):60-68. doi: 10.1002/ags3.12005. eCollection 2017 Apr. Review.

45.

Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance.

Whelan KA, Chandramouleeswaran PM, Tanaka K, Natsuizaka M, Guha M, Srinivasan S, Darling DS, Kita Y, Natsugoe S, Winkler JD, Klein-Szanto AJ, Amaravadi RK, Avadhani NG, Rustgi AK, Nakagawa H.

Oncogene. 2017 Aug 24;36(34):4843-4858. doi: 10.1038/onc.2017.102. Epub 2017 Apr 17.

46.

Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.

Sasaki K, Kurahara H, Young ED, Natsugoe S, Ijichi A, Iwakuma T, Welch DR.

Clin Exp Metastasis. 2017 Apr;34(3-4):229-239. doi: 10.1007/s10585-017-9840-3. Epub 2017 Mar 13.

47.

Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.

Okubo K, Uenosono Y, Arigami T, Yanagita S, Matsushita D, Kijima T, Amatatsu M, Uchikado Y, Kijima Y, Maemura K, Natsugoe S.

Gastric Cancer. 2017 Sep;20(5):802-810. doi: 10.1007/s10120-017-0705-x. Epub 2017 Feb 28.

PMID:
28247164
48.

Clinical impact of circulating tumor cells and therapy response in pancreatic cancer.

Okubo K, Uenosono Y, Arigami T, Mataki Y, Matsushita D, Yanagita S, Kurahara H, Sakoda M, Kijima Y, Maemura K, Natsugoe S.

Eur J Surg Oncol. 2017 Jun;43(6):1050-1055. doi: 10.1016/j.ejso.2017.01.241. Epub 2017 Feb 12. Erratum in: Eur J Surg Oncol. 2018 Mar 28;:.

PMID:
28233633
49.

Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial.

Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M.

Surg Today. 2017 Sep;47(9):1060-1071. doi: 10.1007/s00595-017-1480-3. Epub 2017 Feb 23. Review. Erratum in: Surg Today. 2017 Sep 27;:.

PMID:
28233105
50.

Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.

Sasaki K, Uchikado Y, Okumura H, Omoto I, Kita Y, Arigami T, Uenosono Y, Owaki T, Maemura K, Natsugoe S.

Anticancer Res. 2017 Feb;37(2):859-864.

PMID:
28179343

Supplemental Content

Loading ...
Support Center